{"name":"New Leaf Venture Partners","permalink":"new-leaf-venture-partners-2","crunchbase_url":"http://www.crunchbase.com/financial-organization/new-leaf-venture-partners-2","homepage_url":"http://www.nlvpartners.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"212-213-0006, ext. 27","description":"Health-Care Focused VC Firm","email_address":"info@nlvpartners.com","number_of_employees":null,"founded_year":2005,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"Sprout Group","created_at":"Wed Mar 11 17:52:18 UTC 2009","updated_at":"Tue Aug 04 20:56:58 UTC 2009","overview":"<p>New Leaf Venture Partners is a venture capital firm that invests primarily in healthcare technology. The company typically focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.</p>\n\n<p>The New Leaf Ventures (NLV) team has been built over a decade, originating within Sprout Group, the venture capital affiliate of Credit Suisse First Boston. Sprout Group was formed in 1969 and has historically been one of the leading venture capital firms in the country. The team started to invest in healthcare technology in 1993 and since then, has become a leading venture investor in that sector. In 2005, the entire healthcare technology team of Sprout spun out into NLV. </p>","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/2730/42730v1-max-150x150.png"],[[250,66],"assets/images/resized/0004/2730/42730v1-max-250x250.png"],[[257,68],"assets/images/resized/0004/2730/42730v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"New York City","address1":"Times Square Tower","address2":"7 Times Square, Suite 1603","zip_code":"10036","city":"New York","state_code":"NY","country_code":"USA","latitude":null,"longitude":null},{"description":"Menlo Park","address1":"2500 Sand Hill Road","address2":"Suite 203","zip_code":"94025","city":"Menlo Park","state_code":"CA","country_code":"USA","latitude":37.4211164,"longitude":-122.2064234}],"relationships":[{"is_past":false,"title":"Venture Partner","person":{"first_name":"Reza","last_name":"Zadno","permalink":"reza-zadno","image":{"available_sizes":[[[102,150],"assets/images/resized/0011/6811/116811v1-max-150x150.jpg"],[[144,211],"assets/images/resized/0011/6811/116811v1-max-250x250.jpg"],[[144,211],"assets/images/resized/0011/6811/116811v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Public Investment Director","person":{"first_name":"William","last_name":"Ho","permalink":"william-ho","image":{"available_sizes":[[[102,150],"assets/images/resized/0011/6981/116981v1-max-150x150.jpg"],[[144,211],"assets/images/resized/0011/6981/116981v1-max-250x250.jpg"],[[144,211],"assets/images/resized/0011/6981/116981v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/","source_description":"Amgen, Relypsa and the art of the biotech-spinout-startup-restart","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":29,"company":{"name":"Relypsa","permalink":"relypsa","image":{"available_sizes":[[[150,79],"assets/images/resized/0003/7781/37781v1-max-150x150.png"],[[250,132],"assets/images/resized/0003/7781/37781v1-max-250x250.png"],[[292,155],"assets/images/resized/0003/7781/37781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Capital Funding Report","raised_amount":37000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":4,"funded_day":30,"company":{"name":"Concert Pharmaceuticals","permalink":"concert-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/5452/45452v1-max-150x150.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-250x250.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Capital Funding Report","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":4,"funded_day":21,"company":{"name":"Stromedix","permalink":"stromedix","image":{"available_sizes":[[[150,58],"assets/images/resized/0004/6603/46603v1-max-150x150.png"],[[195,76],"assets/images/resized/0004/6603/46603v1-max-250x250.png"],[[195,76],"assets/images/resized/0004/6603/46603v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/vaxinnate-corp-series-d-30m/","source_description":"VaxInnate Corp., Series D $30M ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":14,"company":{"name":"VaxInnate","permalink":"vaxinnate","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/8849/48849v1-max-150x150.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-250x250.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2009/02/03/reshape-beefs-up-with-20m-to-bust-fat/","source_description":"ReShape beefs up with $20M to bust fat","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":2,"funded_day":3,"company":{"name":"ReShape Medical","permalink":"reshape-medical","image":{"available_sizes":[[[150,74],"assets/images/resized/0004/9666/49666v2-max-150x150.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-250x250.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/visiogen-inc-series-d-40m/","source_description":"Visiogen, Inc.: Series D $40M","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":8,"company":{"name":"Visiogen","permalink":"visiogen","image":{"available_sizes":[[[89,72],"assets/images/resized/0005/0587/50587v1-max-150x150.jpg"],[[89,72],"assets/images/resized/0005/0587/50587v1-max-250x250.jpg"],[[89,72],"assets/images/resized/0005/0587/50587v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://deals.venturebeat.com/2008/07/03/pearl-therapeutics-ups-its-first-round-funding/","source_description":"Pearl Therapeutics ups its first round funding","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":3,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/spiracur-inc-series-b-203m/","source_description":"Spiracur, Inc.: Series B $20.3M","raised_amount":20300000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":29,"company":{"name":"Spiracur","permalink":"spiracur","image":{"available_sizes":[[[120,24],"assets/images/resized/0005/1291/51291v2-max-150x150.png"],[[120,24],"assets/images/resized/0005/1291/51291v2-max-250x250.png"],[[120,24],"assets/images/resized/0005/1291/51291v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/presidio-rounds-27m-clinical-studies/2009-07-10?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Presidio rounds up $27M for clinical studies","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":10,"company":{"name":"Presidio Pharmaceuticals","permalink":"presidio","image":{"available_sizes":[[[150,67],"assets/images/resized/0005/4126/54126v2-max-150x150.jpg"],[[211,95],"assets/images/resized/0005/4126/54126v2-max-250x250.jpg"],[[211,95],"assets/images/resized/0005/4126/54126v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/interlace-medical-inc-series-c-20m/","source_description":"Interlace Medical, Inc.: Series C $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":7,"company":{"name":"Interlace Medical","permalink":"interlace-medical","image":{"available_sizes":[[[100,35],"assets/images/resized/0005/2932/52932v1-max-150x150.jpg"],[[100,35],"assets/images/resized/0005/2932/52932v1-max-250x250.jpg"],[[100,35],"assets/images/resized/0005/2932/52932v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2007/10/03/life-sciences-briefing-wednesday-oct-3-2007/","source_description":"Heart-diagnostic maker Aviir raises $11.3M","raised_amount":11300000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":3,"company":{"name":"Aviir","permalink":"aviir","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/3036/53036v1-max-150x150.jpg"],[[190,66],"assets/images/resized/0005/3036/53036v1-max-250x250.jpg"],[[190,66],"assets/images/resized/0005/3036/53036v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://deals.venturebeat.com/2007/03/08/insomnia-drug-company-transoral-raises-40m-more/","source_description":"Insomnia drug company, TransOral, raises $40M more","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":8,"company":{"name":"Transcept Pharmaceuticals","permalink":"transcept-pharmaceuticals","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/9931/59931v1-max-150x150.jpg"],[[239,87],"assets/images/resized/0005/9931/59931v1-max-250x250.jpg"],[[239,87],"assets/images/resized/0005/9931/59931v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://onbiovc.com/xdx-inc-series-g-144m/","source_description":"XDx, Inc.: Series G $14.4M","raised_amount":14400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":7,"company":{"name":"XDx","permalink":"xdx","image":{"available_sizes":[[[150,68],"assets/images/resized/0005/1083/51083v1-max-150x150.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-250x250.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2009/10/05/direct-flow-medical-takes-40m-for-heart-valve-treatments/","source_description":"Direct Flow Medical takes $40M for heart valve treatments","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":5,"company":{"name":"Direct Flow Medical","permalink":"direct-flow-medical","image":{"available_sizes":[[[150,67],"assets/images/resized/0006/2095/62095v1-max-150x150.jpg"],[[250,112],"assets/images/resized/0006/2095/62095v1-max-250x250.jpg"],[[335,151],"assets/images/resized/0006/2095/62095v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2007/03/20/intarcia-restarts-with-50m-for-hepatitis-diabetes-treatments/","source_description":"Intarcia restarts with $50M for hepatitis, diabetes treatments","raised_amount":null,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":20,"company":{"name":"Intarcia Therapeutics","permalink":"intarcia-therapeutics","image":{"available_sizes":[[[150,85],"assets/images/resized/0006/2213/62213v1-max-150x150.png"],[[157,89],"assets/images/resized/0006/2213/62213v1-max-250x250.png"],[[157,89],"assets/images/resized/0006/2213/62213v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/neuronetics-inc-series-d-30m/","source_description":"Neuronetics, Inc.: Series D $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":27,"company":{"name":"Neuronetics","permalink":"neuronetics","image":{"available_sizes":[[[150,24],"assets/images/resized/0006/3974/63974v1-max-150x150.jpg"],[[250,40],"assets/images/resized/0006/3974/63974v1-max-250x250.jpg"],[[286,46],"assets/images/resized/0006/3974/63974v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.altassets.net/private-equity-news/by-region/north-america/unitedstates/article/nz17085.html","source_description":"Synageva attracts additional $12m to venture funding round","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":22,"company":{"name":"Synageva BioPharma","permalink":"synageva","image":{"available_sizes":[[[150,54],"assets/images/resized/0004/1377/41377v1-max-150x150.png"],[[203,74],"assets/images/resized/0004/1377/41377v1-max-250x250.png"],[[203,74],"assets/images/resized/0004/1377/41377v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2009/12/afferent-pharmaceuticals-closes-23m.html","source_description":"Afferent Pharmaceuticals Closes $23M Series A Financing Round","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":16,"company":{"name":"Afferent Pharmaceuticals","permalink":"afferent-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0007/6112/76112v1-max-150x150.png"],[[250,71],"assets/images/resized/0007/6112/76112v1-max-250x250.png"],[[263,75],"assets/images/resized/0007/6112/76112v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"debt_round","source_url":"http://deals.venturebeat.com/2010/01/19/aviir-diagnoses-heart-conditions-with-new-4-2m/","source_description":"Aviir diagnoses heart conditions with new $4.2M","raised_amount":4200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":19,"company":{"name":"Aviir","permalink":"aviir","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/3036/53036v1-max-150x150.jpg"],[[190,66],"assets/images/resized/0005/3036/53036v1-max-250x250.jpg"],[[190,66],"assets/images/resized/0005/3036/53036v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/pearl-therapeutics-inc-series-c-15m/","source_description":"Pearl Therapeutics, Inc.: Series C $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":5,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.ncbiotech.org/news_and_events/industry_news/oriel_novaward.html","source_description":"Venture Capitalists Invest $26.5M in Oriel Therapeutics","raised_amount":26500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":16,"company":{"name":"Oriel Therapeutics","permalink":"oriel-therapeutics","image":{"available_sizes":[[[150,73],"assets/images/resized/0008/0323/80323v1-max-150x150.jpg"],[[202,99],"assets/images/resized/0008/0323/80323v1-max-250x250.jpg"],[[202,99],"assets/images/resized/0008/0323/80323v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.researchviews.com/healthcare/medical/surgicalequipment/DealReport.aspx?DealID=36870&DealDate=5/11/2009+12:00:00+AM&Industry=Surgical+Equipment&Project=AE","source_description":"ReShape Medical Secures $3 Million in Series A Financing","raised_amount":3000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":31,"company":{"name":"ReShape Medical","permalink":"reshape-medical","image":{"available_sizes":[[[150,74],"assets/images/resized/0004/9666/49666v2-max-150x150.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-250x250.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.tiogapharma.com/press/Tioga%20Feb%202010%20Financing%20PR.pdf","source_description":"Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":17,"company":{"name":"Tioga Pharmaceuticals","permalink":"tioga-pharmaceuticals","image":{"available_sizes":[[[150,58],"assets/images/resized/0007/7570/77570v1-max-150x150.png"],[[250,97],"assets/images/resized/0007/7570/77570v1-max-250x250.png"],[[252,98],"assets/images/resized/0007/7570/77570v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://concertpharma.com/news/2006_1130.html","source_description":"Concert Pharmaceuticals Raises $48.5 Million in Series B Financing","raised_amount":48500000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":30,"company":{"name":"Concert Pharmaceuticals","permalink":"concert-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/5452/45452v1-max-150x150.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-250x250.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.thefreelibrary.com/VaxInnate+Secures+$40+Million+Series+C+Financing-a0153993028","source_description":"VaxInnate Secures $40 Million Series C Financing.","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":10,"funded_day":25,"company":{"name":"VaxInnate","permalink":"vaxinnate","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/8849/48849v1-max-150x150.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-250x250.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://artisanpharma.net/pressReleasepdf.pdf","source_description":"Artisan Pharma, Inc. Raises $39 Million in a Series A Financing Led by NGN Capital LLC","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":9,"funded_day":6,"company":{"name":"Artisan Pharma","permalink":"artisan-pharma","image":{"available_sizes":[[[150,41],"assets/images/resized/0007/4261/74261v1-max-150x150.png"],[[213,59],"assets/images/resized/0007/4261/74261v1-max-250x250.png"],[[213,59],"assets/images/resized/0007/4261/74261v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/aureon-laboratories-series-d-7m/","source_description":"","raised_amount":7000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":14,"company":{"name":"Aureon Laboratories","permalink":"aureon-laboratories","image":{"available_sizes":[[[150,37],"assets/images/resized/0008/4867/84867v1-max-150x150.jpg"],[[250,62],"assets/images/resized/0008/4867/84867v1-max-250x250.jpg"],[[289,72],"assets/images/resized/0008/4867/84867v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/oxford-immunotec-ltd-series-d-26m/","source_description":"Oxford Immunotec, Ltd.: Series D $26M","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":4,"company":{"name":"Oxford Immunotec","permalink":"oxford-immunotec","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/1001/71001v2-max-150x150.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-250x250.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/altura-medical-inc-series-a-20m/","source_description":"Altura Medical, Inc.: Series A $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":3,"company":{"name":"Altura Medical","permalink":"altura-medical","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2010/09/08/intarcia-therapeutics-raises-5m-to-treat-long-term-conditions/","source_description":"Intarcia Therapeutics raises $5M to treat long-term conditions","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":8,"company":{"name":"Intarcia Therapeutics","permalink":"intarcia-therapeutics","image":{"available_sizes":[[[150,85],"assets/images/resized/0006/2213/62213v1-max-150x150.png"],[[157,89],"assets/images/resized/0006/2213/62213v1-max-250x250.png"],[[157,89],"assets/images/resized/0006/2213/62213v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/relypsa-raises-70m-in-series-b.html","source_description":"Relypsa Raises $70M in Series B Financing","raised_amount":70000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":13,"company":{"name":"Relypsa","permalink":"relypsa","image":{"available_sizes":[[[150,79],"assets/images/resized/0003/7781/37781v1-max-150x150.png"],[[250,132],"assets/images/resized/0003/7781/37781v1-max-250x250.png"],[[292,155],"assets/images/resized/0003/7781/37781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2010/10/convergence-pharmaceuticals-raises-354m.html","source_description":"Convergence Pharmaceuticals Raises $35.4M in Series A Financing","raised_amount":35400000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":5,"company":{"name":"Convergence Pharmaceuticals","permalink":"convergence-pharmaceuticals","image":{"available_sizes":[[[150,31],"assets/images/resized/0010/4669/104669v1-max-150x150.png"],[[250,51],"assets/images/resized/0010/4669/104669v1-max-250x250.png"],[[385,80],"assets/images/resized/0010/4669/104669v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/pearl-lands-69m-series-c-mid-stage-copd-program/2010-10-19?utm_medium=rss&utm_source=rss","source_description":"Pearl lands $69M Series C for mid-stage COPD program","raised_amount":69000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":19,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://finance.yahoo.com/news/World-Heart-Corp-Completes-pz-1133292728.html?x=0&.v=1","source_description":"World Heart Corp. Completes Private Placement of $25.3 Million","raised_amount":25300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":20,"company":{"name":"WorldHeart","permalink":"worldheart","image":{"available_sizes":[[[150,25],"assets/images/resized/0010/7510/107510v1-max-150x150.jpg"],[[250,42],"assets/images/resized/0010/7510/107510v1-max-250x250.jpg"],[[302,51],"assets/images/resized/0010/7510/107510v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.masshightech.com/stories/2010/07/19/daily26-Artisan-Pharma-adds-3M-to-coffers-in-new-round.html","source_description":"Artisan Pharma adds $3M to coffers in new round","raised_amount":3000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":20,"company":{"name":"Artisan Pharma","permalink":"artisan-pharma","image":{"available_sizes":[[[150,41],"assets/images/resized/0007/4261/74261v1-max-150x150.png"],[[213,59],"assets/images/resized/0007/4261/74261v1-max-250x250.png"],[[213,59],"assets/images/resized/0007/4261/74261v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/02/spiracur-closes-35m-equity-financing.html","source_description":"Spiracur Closes $35M Equity Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":1,"company":{"name":"Spiracur","permalink":"spiracur","image":{"available_sizes":[[[120,24],"assets/images/resized/0005/1291/51291v2-max-150x150.png"],[[120,24],"assets/images/resized/0005/1291/51291v2-max-250x250.png"],[[120,24],"assets/images/resized/0005/1291/51291v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.masshightech.com/stories/2011/01/31/daily42-Spine-Wave-rounds-up-175M-financing.html","source_description":"Spine Wave rounds up $17.5M financing","raised_amount":17500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":2,"company":{"name":"Spine Wave","permalink":"spine-wave","image":null}}},{"funding_round":{"round_code":"f","source_url":"http://www.chimerix-inc.com/news-and-resources/news-and-resources-details/chimerix-completes-45-million-financing/","source_description":"Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 ","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":14,"company":{"name":"Chimerix","permalink":"chimerix","image":{"available_sizes":[[[150,60],"assets/images/resized/0005/6041/56041v1-max-150x150.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-250x250.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.versartis.com/content/newsandevents/releases/021611.htm","source_description":"Versartis Completes $21 Million Series B Financing","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":16,"company":{"name":"Versartis","permalink":"versartis","image":{"available_sizes":[[[150,41],"assets/images/resized/0004/9154/49154v1-max-150x150.png"],[[250,69],"assets/images/resized/0004/9154/49154v1-max-250x250.png"],[[262,73],"assets/images/resized/0004/9154/49154v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2011/03/21/daily5-Synageva-finds-25M-financing-for-enzyme-treatment.html","source_description":"Synageva finds $25M financing for enzyme treatment","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":21,"company":{"name":"Synageva BioPharma","permalink":"synageva","image":{"available_sizes":[[[150,54],"assets/images/resized/0004/1377/41377v1-max-150x150.png"],[[203,74],"assets/images/resized/0004/1377/41377v1-max-250x250.png"],[[203,74],"assets/images/resized/0004/1377/41377v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.irhythmtech.com/company/news-and-events/","source_description":"iRhythm Technologies, Inc. Raises $15 Million Series C Equity Round","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":4,"company":{"name":"iRhythm Technologies","permalink":"irhythm","image":{"available_sizes":[[[122,68],"assets/images/resized/0004/6028/46028v1-max-150x150.png"],[[122,68],"assets/images/resized/0004/6028/46028v1-max-250x250.png"],[[122,68],"assets/images/resized/0004/6028/46028v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.marketwire.com/press-release/neuronetics-inc-raises-30-million-in-series-e-financing-1514679.htm","source_description":"Neuronetics, Inc. Raises $30 Million in Series E Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":16,"company":{"name":"Neuronetics","permalink":"neuronetics","image":{"available_sizes":[[[150,24],"assets/images/resized/0006/3974/63974v1-max-150x150.jpg"],[[250,40],"assets/images/resized/0006/3974/63974v1-max-250x250.jpg"],[[286,46],"assets/images/resized/0006/3974/63974v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.finsmes.com/2011/09/cardiokinetix-raises-44m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"CardioKinetix Raises $44M in Series E Financing","raised_amount":44000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":21,"company":{"name":"CardioKinetix","permalink":"cardiokinetix","image":{"available_sizes":[[[150,19],"assets/images/resized/0015/5136/155136v1-max-150x150.png"],[[250,32],"assets/images/resized/0015/5136/155136v1-max-250x250.png"],[[250,32],"assets/images/resized/0015/5136/155136v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/aviir-inc-series-e-10m/","source_description":"Aviir, Inc.: Series E $10M","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":20,"company":{"name":"Aviir","permalink":"aviir","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/3036/53036v1-max-150x150.jpg"],[[190,66],"assets/images/resized/0005/3036/53036v1-max-250x250.jpg"],[[190,66],"assets/images/resized/0005/3036/53036v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/02/truveris-closes-10m-series-venture-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Truveris Closes $10M Series B Venture Funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":23,"company":{"name":"Truveris","permalink":"truveris","image":{"available_sizes":[[[150,50],"assets/images/resized/0012/0047/120047v2-max-150x150.jpg"],[[213,71],"assets/images/resized/0012/0047/120047v2-max-250x250.jpg"],[[213,71],"assets/images/resized/0012/0047/120047v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.masshightech.com/stories/2007/06/11/daily6-Nutmeg-State-biotech-lands-258M-in-round-one.html","source_description":"Nutmeg State biotech lands $25.8M in round one","raised_amount":25800000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":11,"company":{"name":"BioRelix","permalink":"biorelix","image":{"available_sizes":[[[150,70],"assets/images/resized/0011/5274/115274v1-max-150x150.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-250x250.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2012/03/19/daily44-Connecticut-biotech-raises-256M-round.html","source_description":"Connecticut biotech raises $2.56M round","raised_amount":2560000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":22,"company":{"name":"BioRelix","permalink":"biorelix","image":{"available_sizes":[[[150,70],"assets/images/resized/0011/5274/115274v1-max-150x150.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-250x250.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.tiogapharma.com/press/BioWorldToday1092006.pdf","source_description":"TiogaÂ’s Series A Round: $24M For Phase IIb Trial Of IBS Drug","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":9,"company":{"name":"Tioga Pharmaceuticals","permalink":"tioga-pharmaceuticals","image":{"available_sizes":[[[150,58],"assets/images/resized/0007/7570/77570v1-max-150x150.png"],[[250,97],"assets/images/resized/0007/7570/77570v1-max-250x250.png"],[[252,98],"assets/images/resized/0007/7570/77570v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120604e864qqdbv&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120604e864qqdbv%26from%3dalert%26pid%3d32","source_description":"Awarepoint Tracks $14M for Hospital Workflow-Management Technology ","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":4,"company":{"name":"Awarepoint","permalink":"awarepoint","image":{"available_sizes":[[[150,38],"assets/images/resized/0009/4399/94399v2-max-150x150.jpg"],[[250,63],"assets/images/resized/0009/4399/94399v2-max-250x250.jpg"],[[327,83],"assets/images/resized/0009/4399/94399v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/06/oxford-immunotec-raises-28m-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Oxford Immunotec Raises $28M in Equity Financing","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":18,"company":{"name":"Oxford Immunotec","permalink":"oxford-immunotec","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/1001/71001v2-max-150x150.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-250x250.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120906e896oaipx&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120906e896oaipx%26from%3dalert%26pid%3d32","source_description":"Karus Thera Picks Up $7.6M to Develop Two Preclinical Compounds","raised_amount":7600000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":6,"company":{"name":"Karus Therapeutics ","permalink":"karus-therapeutics","image":{"available_sizes":[[[150,59],"assets/images/resized/0021/0236/210236v1-max-150x150.jpg"],[[250,99],"assets/images/resized/0021/0236/210236v1-max-250x250.jpg"],[[261,104],"assets/images/resized/0021/0236/210236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.marketwire.com/press-release/illuminoss-medical-secures-28-million-series-c-financing-minimally-invasive-bone-fracture-nyse-hqh-1706365.htm","source_description":"IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture Repair","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":27,"company":{"name":"IlluminOss Medical","permalink":"illuminoss-medical","image":{"available_sizes":[[[150,45],"assets/images/resized/0016/4547/164547v1-max-150x150.jpg"],[[250,75],"assets/images/resized/0016/4547/164547v1-max-250x250.jpg"],[[328,99],"assets/images/resized/0016/4547/164547v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020121023e8anshyya&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121023e8anshyya%26from%3dalert%26pid%3d32","source_description":"Obesity-Device Maker ReShape Medical Raises More Than $15M of $20M Series C","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":23,"company":{"name":"ReShape Medical","permalink":"reshape-medical","image":{"available_sizes":[[[150,74],"assets/images/resized/0004/9666/49666v2-max-150x150.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-250x250.png"],[[166,82],"assets/images/resized/0004/9666/49666v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.bizjournals.com/sacramento/prnewswire/press_releases/California/2012/10/29/NY01747","source_description":"Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team","raised_amount":12500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":29,"company":{"name":"Principia BioPharma","permalink":"principia-biopharma","image":{"available_sizes":[[[150,31],"assets/images/resized/0021/7842/217842v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0021/7842/217842v1-max-250x250.jpg"],[[394,82],"assets/images/resized/0021/7842/217842v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://finance.yahoo.com/news/advanced-cell-diagnostics-completes-12-120000869.html","source_description":"Advanced Cell Diagnostics Completes $12 Million Series B Financing","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":1,"company":{"name":"Advanced Cell Diagnostics","permalink":"advanced-cell-diagnostics","image":{"available_sizes":[[[150,68],"assets/images/resized/0021/8380/218380v1-max-150x150.jpg"],[[209,95],"assets/images/resized/0021/8380/218380v1-max-250x250.jpg"],[[209,95],"assets/images/resized/0021/8380/218380v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/11/pearl-therapeutics-raises-65m-series-financing.html","source_description":"Pearl Therapeutics Raises $65M in Series D Financing","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Life Sciences Fund","funded_year":2007,"funded_month":10,"funded_day":10,"raised_amount":450000000,"raised_currency_code":"USD","source_url":"http://deals.venturebeat.com/2007/10/10/new-leaf-raises-450m-life-sciences-fund/","source_description":"New Leaf raises $450M life-sciences fund"}],"video_embeds":[],"external_links":[]}